Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Greenlight Biosciences
company
About
GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.
- Medford,Massachusetts,United States
- 251 - 500
- https://www.greenlightbiosciences.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $109M
- Industries
- Agriculture,AgTech,Biotechnology,Life Science
- Founded date
- Jan 1, 2008
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Stock Symbol
- nasdaq:GRNA
- Legal Name
- Greenlight Biosciences Inc.
GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower cost and more quickly than was ever before possible. GreenLight develops RNA products and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, plant protection and support the health of bees and other pollinators.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
11
$731.50M
Greenlight Biosciences has raised a total of
$731.50M
in funding over 2 rounds. Their latest funding was raised on
Aug 12, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 12, 2022 | Post-IPO Equity | $109M | 12 | — | — | Detail |
| Feb 3, 2022 | Post-IPO Equity | $125.50M | 15 | — | — | Detail |
| Feb 3, 2022 | IPO | $282M | — | — | — | Detail |
| Jun 16, 2020 | Series D | $102M | 12 |
Morningside Venture Partners
|
— | Detail |
| May 12, 2020 | Series Unknown | $17M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
6
34
Greenlight Biosciences is funded by 34 investors.
Morningside Venture Partners
and Khosla Ventures
are the most recent investors.
Employee Profiles
Number of Employee Profiles
29
Greenlight Biosciences has 29 current employee profiles, including
Executive James R. Swartz
Executive
Executive
Advisor
Executive
Advisor
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
